Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.

Zerp SF, Stoter TR, Hoebers FJ, van den Brekel MW, Dubbelman R, Kuipers GK, Lafleur MV, Slotman BJ, Verheij M.

Radiat Oncol. 2015 Jul 30;10:158. doi: 10.1186/s13014-015-0474-9.

2.

NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study.

Zerp SF, Vens C, Floot B, Verheij M, van Triest B.

Radiother Oncol. 2014 Feb;110(2):348-54. doi: 10.1016/j.radonc.2013.10.039. Epub 2014 Jan 8.

PMID:
24412016
3.

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.

Zerp SF, Stoter R, Kuipers G, Yang D, Lippman ME, van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur V, Verheij M.

Radiat Oncol. 2009 Oct 23;4:47. doi: 10.1186/1748-717X-4-47.

4.

Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.

Zerp SF, Vink SR, Ruiter GA, Koolwijk P, Peters E, van der Luit AH, de Jong D, Budde M, Bartelink H, van Blitterswijk WJ, Verheij M.

Anticancer Drugs. 2008 Jan;19(1):65-75.

PMID:
18043131
5.

In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.

Haas RL, de Jong D, Valdés Olmos RA, Hoefnagel CA, van den Heuvel I, Zerp SF, Bartelink H, Verheij M.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):782-7.

PMID:
15183481
6.

Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.

Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M.

Anticancer Drugs. 2003 Feb;14(2):167-73.

PMID:
12569304
7.
8.

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M.

Radiother Oncol. 2001 Nov;61(2):169-75.

PMID:
11690683
9.

Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.

Ruiter GA, Verheij M, Zerp SF, van Blitterswijk WJ.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):415-9. Review.

PMID:
11173135
10.

Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.

Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M.

Cancer Res. 1999 May 15;59(10):2457-63.

11.

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.

Zerp SF, van Elsas A, Peltenburg LT, Schrier PI.

Br J Cancer. 1999 Feb;79(5-6):921-6.

12.

The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis.

Verheij M, Ruiter GA, Zerp SF, van Blitterswijk WJ, Fuks Z, Haimovitz-Friedman A, Bartelink H.

Radiother Oncol. 1998 Jun;47(3):225-32. Review.

PMID:
9681884
13.

UV-induced N-ras mutations are T-cell targets in human melanoma.

van Elsas A, Scheibenbogen C, van der Minne C, Zerp SF, Keilholz U, Schrier PI.

Melanoma Res. 1997 Aug;7 Suppl 2:S107-13. Review.

PMID:
9578425
14.

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

van Elsas A, Zerp SF, van der Flier S, Krüse KM, Aarnoudse C, Hayward NK, Ruiter DJ, Schrier PI.

Am J Pathol. 1996 Sep;149(3):883-93.

15.

Separate structural elements within internal transcribed spacer 1 of Saccharomyces cerevisiae precursor ribosomal RNA direct the formation of 17S and 26S rRNA.

van Nues RW, Rientjes JM, van der Sande CA, Zerp SF, Sluiter C, Venema J, Planta RJ, Raué HA.

Nucleic Acids Res. 1994 Mar 25;22(6):912-9.

Supplemental Content

Support Center